Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup ...

Epic’s lawsuit against Health Gorilla is less about one alleged data misuse scheme and more about a deeper fault line in healthcare interoperability: data can move faster than the rules governing it.

This week, Congress reached a bipartisan healthcare deal as part of a larger $1.2 trillion spending bill, combining funding ...

As OpenAI and Anthropic move deeper into healthcare, experts say AI chatbots are becoming the new front door to medicine. This shift is shaking things up for some health tech startups, redefining the ...

About 31,000 Kaiser Permanente healthcare workers plan to launch an open-ended strike over staffing shortages, wages and care access issues — potentially affecting dozens of hospitals and hundreds of ...

The gradual loss of near vision that is a natural part of aging can be addressed by glasses, contact lenses, or even surgical procedures. A presbyopia eye drop developed by Tenpoint Therapeutics now ...

During two House hearings, health insurance CEOs were questioned on rising healthcare costs, vertical integration and prior authorization.

As more hospitals and medical practices assess AI applications to improve medical bill collection and revenue cycle management more broadly, it’s a good opportunity to discuss what healthcare ...

Pfizer is getting out of the business of developing and marketing HIV medicines by exiting its minority stake in ViiV Healthcare, a company the pharmaceutical giant formed in partnership with GSK 17 ...

For decades, drug safety has depended on one simple but demanding task: turning fragments of information from patients, physicians, and trials into clear signals that protect lives. Today, that ...

The healthcare AI world will likely undergo another year of rapid transformation in 2026, colored by fast-moving experimentation and adoption, according to a report published this week by Bessemer ...

Cancer is appearing in Americans earlier than ever before. However, many younger people are missing out on their screenings, which can lead to later-stage diagnoses with worse outcomes. Blood-based ...